Premium
BICENTRIC PILOT STUDY ON AGE‐ADAPTED HIGH‐DOSE CHEMOTHERAPY AND AUTOLOGOUS STEM CELL TRANSPLANT IN NEWLY DIAGNOSED PRIMARY CNS LYMPHOMA PATIENTS > 65 YEARS ‐ MARiTA TRIAL
Author(s) -
Schorb E.,
Kasenda B.,
Ihorst G.,
Fricker H.,
Holl H.,
Finke J.,
Illerhaus G.
Publication year - 2019
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.81_2630
Subject(s) - medicine , thiotepa , autologous stem cell transplantation , primary central nervous system lymphoma , surgery , chemotherapy , transplantation , rituximab , chemotherapy regimen , performance status , oncology , lymphoma , cyclophosphamide